Sunday 21 January 2018 ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

Optibiotix Not the news we hoped for that will be the late Easter present

By HotStockRockets | Thursday 24 March 2016

Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Shares in Optibiotix (OPTI) slipped back to 66.5p - albeit in thin volumes - two days ago as it announced news which was really not very exciting at all. The news we want we now expect very shortly after Easter. The shares are now 70p. Hang on for what comes next!

So what did Optibiotix say? It has signed a second deal with the IQOG (Instituto de Química Orgánica General) of the Spanish National Research Council (Consejo Superior de Investigaciones Científicas, CSIC) in Madrid extending OptiBiotix development programmes creating sweet healthy oligosaccharides (carbohydrates that consists of a small number of sugars).

So why is this different to deal 1? Optibiotix clarifies:

The first research programme which started in September 2015, is designed to create sweet low calorie sugars using different bacterial strains.
This second program incorporates natural sweeteners into existing or new oligosaccharide chains with the potential to create sweet products with functional health benefits.


What the market wants is a deal stating explicitly that its alternatives to sugar will generate cash. It is that simple. We believe such deals with hard numbers included are very imminent indeed and that this will see the shares jump sharply. So the stance is buy. It is that simple.

To catch the next share tip from HotStockRockets out at noon on Tuesday 29th March for just £5 click HERE

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on OPTI



  1. Lactobacillus

    Not just imminent news this time, but “very imminent” ? I bought more shares based on the last imminent news tip only to see the share price drop back again. I shall put my trust in HSR yet again and buy a few more.

  2. Is the agreement announced today with Royal DSM the imminent news vaunted after Easter? or are you still expecting another “imminent” but actual commercial tie up deal.

Enter your comment below. Fields marked * are required. You must preview your comment first before finally posting.

Site by Everywhen